CVE-2022-37461
Published: 30 September 2022
Summary
CVE-2022-37461 is a medium-severity Cross-site Scripting (CWE-79) vulnerability in Canon Medical Vitrea View. Its CVSS base score is 6.1 (Medium).
Operationally, ranked in the top 28.2% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.
EU & UK References
- 🇪🇺 ENISA EUVD: EUVD-2022-40086
Vulnerability details
Multiple cross-site scripting (XSS) vulnerabilities in Canon Medical Vitrea View 7.x before 7.7.6 allow remote attackers to inject arbitrary web script or HTML via (1) the input after the error subdirectory to the /vitrea-view/error/ subdirectory, or the (2) groupID, (3)…
more
offset, or (4) limit parameter to an Administrative Panel (Group and Users) page. There is a risk of an attacker retrieving patient information.
- CWE(s)
Related Threats
No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.
Affected Assets
Mitigating Controls
Likely Mitigating Controls AI
Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.
Penetration testing submits XSS payloads to web applications, detecting cross-site scripting flaws for subsequent remediation.
Validates web inputs to reject script-related content that could produce XSS.
Output validation against expected content can reject or sanitize script content in generated web pages, reducing XSS exploitability.